| |
Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses
Am J Cardiol, 2009. 103(7): p. 943-9.
J. Courtis, et al., |
| |
Comparison of long-term efficacy of the paclitaxel-eluting stent versus the bare-metal stent for treatment of unprotected left main coronary artery disease
Am J Cardiol, 2009. 103(2): p. 194-8.
Y. Han, et al., |
| |
Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes
Am J Cardiol, 2009. 103(2): p. 187-93.
C. Tamburino, et al., |
| |
Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry
Catheter Cardiovasc Interv, 2009. 73(3): p. 310-6.
D. Capodanno, et al., |
| |
Left main intervention in myocardial infarction
Catheter Cardiovasc Interv, 2009.
M. T. Castagna, M. C. Machado and J. V. de Oliveira, |
| |
Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial
Catheter Cardiovasc Interv, 2009. 73(1): p. 34-41.
T. Hasegawa, et al., |
| |
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction
Catheter Cardiovasc Interv, 2009. 73(1): p. 15-21.
M. S. Lee, et al., |
| |
Coronary revascularization for patients with unprotected left main coronary artery disease: evidence, guidelines, and judgment! Making clinical decisions in 2009
Catheter Cardiovasc Interv, 2009. 74(3): p. 448-58.
I. D. Moussa, S. C. Wong and T. Feldman, |
| |
Primary percutaneous coronary intervention for acute myocardial infarction caused by unprotected left main stem thrombosis
Catheter Cardiovasc Interv, 2009. 73(3): p. 301-7.
S. B. Prasad, et al., |
| |
Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation disease
Catheter Cardiovasc Interv, 2009. 73(1): p. 25-31.
I. Sheiban, et al., |
| |
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease
Catheter Cardiovasc Interv, 2009. 73(3): p. 291-8.
C. Tamburino, et al., |
| |
Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG
Catheter Cardiovasc Interv, 2009. 74(2): p. 302-10.
P. Vranckx, et al., |
| |
Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease
Circ Cardiovasc Interv, 2009. 2(4): p. 302-8.
D. Capodanno, et al., |
| |
Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis
Circ Cardiovasc Interv, 2009. 2(3): p. 167-77.
S. J. Park, et al., |
| |
Percutaneous coronary intervention with stent implantation versus coronary artery bypass surgery for treatment of left main coronary artery disease: is it time to change guidelines?
Circ Cardiovasc Interv, 2009. 2(1): p. 59-68.
S. J. Park and D. W. Park, |
| |
Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis
Circulation, 2009. 120(15): p. 1505-12.
M. Hamilos, et al., |
| |
Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents
Circulation, 2009. 120(5): p. 400-7.
Y. H. Kim, et al., |
| |
High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease
Circulation, 2009. 120(22): p. 2214-21.
A. Migliorini, et al., |
| |
Surgery, not percutaneous revascularization, is the preferred strategy for patients with significant left main coronary stenosis
Circulation, 2009. 119(7): p. 1013-20.
C. R. Smith, |
| |
Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: insights from the j-Cypher registry
Circulation, 2009. 120(19): p. 1866-74.
M. Toyofuku, et al., |
| |
Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry
Circulation, 2009. 119(17): p. 2349-56.
B. Vaquerizo, et al., |
| |
Simultaneous quadruple kissing stenting of an unprotected left main coronary artery
Eur Heart J, 2009.
C. L. Dubois, P. Kayaert and W. Desmet, |
| |
Unprotected left main revascularization in patients with acute coronary syndromes
Eur Heart J, 2009. 30(19): p. 2308-17.
G. Montalescot, et al., |
| |
Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology
Eur Heart J, 2009. 30(17): p. 2087-94.
T. Palmerini, et al., |
| |
Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry
Eur Heart J, 2009. 30(10): p. 1171-9.
C. Tamburino, et al., |
| |
Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry
J Am Coll Cardiol, 2009. 54(16): p. 1500-11.
P. E. Buszman, et al., |
| |
Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards
J Am Coll Cardiol, 2009. 54(17): p. 1576-88.
D. E. Kandzari, et al., |
| |
Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry
J Am Coll Cardiol, 2009. 54(9): p. 853-9.
J. Y. Lee, et al., |
| |
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease
J Am Coll Cardiol, 2009. 53(19): p. 1760-8.
J. Mehilli, et al., |
| |
Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention
J Am Coll Cardiol, 2009. 53(14): p. 1176-81.
T. Palmerini, et al., |
| |
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study)
J Am Coll Cardiol, 2009. 54(13): p. 1131-6.
I. Sheiban, et al., |
| |
| |
| |
 |